Cargando…
Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity
Oxidative stress is caused by an imbalance between the generation and detoxification of reactive oxygen and nitrogen species (ROS/RNS). This imbalance plays an important role in brain aging and age-related neurodegenerative diseases. In the context of Parkinson’s disease (PD), the sensitivity of dop...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298686/ https://www.ncbi.nlm.nih.gov/pubmed/35398340 http://dx.doi.org/10.1016/j.nbd.2022.105719 |
_version_ | 1784750765756121088 |
---|---|
author | Pamies, David Wiersma, Daphne Katt, Moriah E. Zhao, Liang Burtscher, Johannes Harris, Georgina Smirnova, Lena Searson, Peter C. Hartung, Thomas Hogberg, Helena T. |
author_facet | Pamies, David Wiersma, Daphne Katt, Moriah E. Zhao, Liang Burtscher, Johannes Harris, Georgina Smirnova, Lena Searson, Peter C. Hartung, Thomas Hogberg, Helena T. |
author_sort | Pamies, David |
collection | PubMed |
description | Oxidative stress is caused by an imbalance between the generation and detoxification of reactive oxygen and nitrogen species (ROS/RNS). This imbalance plays an important role in brain aging and age-related neurodegenerative diseases. In the context of Parkinson’s disease (PD), the sensitivity of dopaminergic neurons in the substantia nigra pars compacta to oxidative stress is considered a key factor of PD pathogenesis. Here we study the effect of different oxidative stress-inducing compounds (6-OHDA, MPTP or MPP(+)) on the population of dopaminergic neurons in an iPSC-derived human brain 3D model (aka BrainSpheres). Treatment with 6-OHDA, MPTP or MPP(+) at 4 weeks of differentiation disrupted the dopaminergic neuronal phenotype in BrainSpheres at (50, 5000, 1000 μM respectively). 6-OHDA increased ROS production and decreased mitochondrial function most efficiently. It further induced the greatest changes in gene expression and metabolites related to oxidative stress and mitochondrial dysfunction. Co-culturing BrainSpheres with an endothelial barrier using a transwell system allowed the assessment of differential penetration capacities of the tested compounds and the damage they caused in the dopaminergic neurons within the BrainSpheres In conclusion, treatment with compounds known to induce PD-like phenotypes in vivo caused molecular deficits and loss of dopaminergic neurons in the BrainSphere model. This approach therefore recapitulates common animal models of neurodegenerative processes in PD at similarly high doses. The relevance as tool for drug discovery is discussed. |
format | Online Article Text |
id | pubmed-9298686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-92986862022-07-20 Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity Pamies, David Wiersma, Daphne Katt, Moriah E. Zhao, Liang Burtscher, Johannes Harris, Georgina Smirnova, Lena Searson, Peter C. Hartung, Thomas Hogberg, Helena T. Neurobiol Dis Article Oxidative stress is caused by an imbalance between the generation and detoxification of reactive oxygen and nitrogen species (ROS/RNS). This imbalance plays an important role in brain aging and age-related neurodegenerative diseases. In the context of Parkinson’s disease (PD), the sensitivity of dopaminergic neurons in the substantia nigra pars compacta to oxidative stress is considered a key factor of PD pathogenesis. Here we study the effect of different oxidative stress-inducing compounds (6-OHDA, MPTP or MPP(+)) on the population of dopaminergic neurons in an iPSC-derived human brain 3D model (aka BrainSpheres). Treatment with 6-OHDA, MPTP or MPP(+) at 4 weeks of differentiation disrupted the dopaminergic neuronal phenotype in BrainSpheres at (50, 5000, 1000 μM respectively). 6-OHDA increased ROS production and decreased mitochondrial function most efficiently. It further induced the greatest changes in gene expression and metabolites related to oxidative stress and mitochondrial dysfunction. Co-culturing BrainSpheres with an endothelial barrier using a transwell system allowed the assessment of differential penetration capacities of the tested compounds and the damage they caused in the dopaminergic neurons within the BrainSpheres In conclusion, treatment with compounds known to induce PD-like phenotypes in vivo caused molecular deficits and loss of dopaminergic neurons in the BrainSphere model. This approach therefore recapitulates common animal models of neurodegenerative processes in PD at similarly high doses. The relevance as tool for drug discovery is discussed. 2022-07 2022-04-07 /pmc/articles/PMC9298686/ /pubmed/35398340 http://dx.doi.org/10.1016/j.nbd.2022.105719 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Pamies, David Wiersma, Daphne Katt, Moriah E. Zhao, Liang Burtscher, Johannes Harris, Georgina Smirnova, Lena Searson, Peter C. Hartung, Thomas Hogberg, Helena T. Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity |
title | Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity |
title_full | Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity |
title_fullStr | Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity |
title_full_unstemmed | Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity |
title_short | Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity |
title_sort | human ipsc 3d brain model as a tool to study chemical-induced dopaminergic neuronal toxicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298686/ https://www.ncbi.nlm.nih.gov/pubmed/35398340 http://dx.doi.org/10.1016/j.nbd.2022.105719 |
work_keys_str_mv | AT pamiesdavid humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT wiersmadaphne humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT kattmoriahe humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT zhaoliang humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT burtscherjohannes humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT harrisgeorgina humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT smirnovalena humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT searsonpeterc humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT hartungthomas humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity AT hogberghelenat humanipsc3dbrainmodelasatooltostudychemicalinduceddopaminergicneuronaltoxicity |